EMN develops and commercializes medical nutrition products aimed at helping patients prepare better and recover faster from surgery. Its flagship product, PREcovery, is an evidence-based preoperative carbohydrate beverage designed to reduce length of stay and improve patient experience during surgery. The company's clinical nutrition pipeline also includes products intended to improve protein metabolism and immune function, supporting a patient's journey before and after surgery. Founded in 2016 and headquartered in Toronto, EMN says it is building commercial operations across North America and Southeast Asia. Management intends to onboard distribution networks and clinical programs to drive surgical quality improvement and accelerate the standard of care globally. Financially, EMN completed an oversubscribed $1.2 million seed round to support these commercial and clinical efforts.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2019